Switch View
© BusinessWire
16.09.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Announces Chief Financial Officer Transition
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that Flavia H. Pease, Corporate Executive Vice President and Chief Financial Officer (CFO), has resigned from her role, effective September 29, 2025, to pursue another opportunity. Following Ms. Pease’s departure, Michael G. Knell, Corporate Senior Vice President and Chief...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US23283X2062
Cytosorbents Corp
CTSO
LISTED
NASDAQ
CytoSorbents Provides DrugSorb-ATR Regulatory Update
News Preview
PRINCETON, N.J., Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory update on DrugSorb™-ATR....
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: CA23344H1091
DRI Healthcare Trust
DHT.U
LISTED
TSX
DRI Healthcare to Present at Upcoming Investor Conferences
News Preview
TORONTO, Sept. 16, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, today announced that it will present at the following investor conferences in September and October:...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
16.09.2025
ISIN: US75955J4022
Relmada Therapeutics Inc
RLMD
LISTED
NASDAQ
Relmada Regains Compliance with Nasdaq Minimum Bid Price Requirement
News Preview
CORAL GABLES, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology-related and central nervous system indications, today announced that on September 15, 2025 it received written notice from the Nasdaq Stock...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
16.09.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award
News Preview
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US91307C1027
United Therapeutics Corp
UTHR
LISTED
NASDAQ
United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum
News Preview
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer, will provide an overview and update on the company during a fireside chat session at the Bernstein 2nd Annual Healthcare Forum in New York.
The session will take place on Tuesday, S...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US45784P1012
Insulet Corp
PODD
LISTED
NASDAQ
Insulet Announces CFO Transition
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Flavia Pease will succeed Ana Maria Chadwick as Executive Vice President, Chief Financial Officer, effective September 30, 2025. Ms. Chadwick will become a Senior Advisor t...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron presents H1 2025 results and provides business update
News Preview
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results and operational highlights for the half-year ended June 30, 2025, and provided a business update f...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum on Tuesday, September 23, 2025.
The company will take part in a fireside chat beginning at 9:40 a.m. ET.
Investors and the general public are invited to listen to the sess...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Becker’s Names Phreesia’s Sara DiNardo as one of 2025’s Rising Stars of Healthcare
News Preview
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sara DiNardo, Vice President of Client Solutions, has been named in Becker’s Hospital Review’s 2025 list of Rising Stars: 100 Healthcare Leaders Under 40.
"A new generation of bold, innovative healthcare leaders is making healthcare more accessible, affordab...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US6283411097
Oncotelic Therapeutics, Inc.
OTLC
LISTED
OTC
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
News Preview
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and cont...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
News Preview
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
16.09.2025
ISIN: CA22587M1068
Cresco Labs Inc
CL
LISTED
CSE
Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership
News Preview
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside in Proctorville, Ohio. It is the Company’s sixth dispensary in Ohio and 71st nationwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916774840/en/...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US82711P2011
Silo Pharma, Inc.
SILO
LISTED
NASDAQ
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
News Preview
Strategic capital deployment advances Company’s blockchain treasury model and biopharma development initiatives...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05280R1005
Autolus Therapeutics plc
AUTL
LISTED
NASDAQ
Autolus Therapeutics to Present Clinical Data Update at the American College of Rheumatology (ACR) Convergence 2025
News Preview
Autolus announces the publication of an abstract submitted to the American College of Rheumatology (ACR) Convergence 2025, to be held October 24-29, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Strengthens Patent Portfolio for Iadademstat and Vafidemstat with New Decisions to Grant
News Preview
In Australia and Europe In Australia and Europe...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US00688A2050
Adial Pharmaceuticals Inc
ADIL
LISTED
NASDAQ
Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04
News Preview
FDA Minutes Reflect Constructive Dialogue and Successful Meeting Outcome with Alignment on Upcoming Phase 3 Clinical Trial Design for AD04 In Alcohol Use Disorder FDA Minutes Reflect Constructive Dialogue and Successful Meeting Outcome with Alignment on Upcoming Phase 3 Clinical Trial Design for AD04 In Alcohol Use Disorder...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US21833P3010
Corbus Pharmaceuticals Holdings Inc
CRBP
LISTED
NASDAQ
FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma
News Preview
NORWOOD, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage oncology and obesity company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CRB-701 for the treatment of recurrent or metastatic head and nec...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05479K1060
Elutia Inc
AZYO
LISTED
NASDAQ
Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
News Preview
- Findings highlight the potential of antibiotic-eluting bioenvelopes to transform cardiac implantable electronic device (CIED) pocket management -...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding
News Preview
A Media Snippet accompanying this announcement is available by clicking on this link....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US70261F1030
Pasithea Therapeutics Corp.
KTTA
LISTED
NASDAQ
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
News Preview
Pasithea Tx (Nasdaq: KTTA) activates South Korea trial sites, dosing first NF1 patient in Phase 1/1b NF1 study at Asan Medical Ctr. and Severance Hospital....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US4169061052
Harvard Bioscience Inc
HBIO
LISTED
NASDAQ
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
News Preview
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US09077A1060
Biomea Fusion Inc
BMEA
LISTED
NASDAQ
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update
News Preview
SAN CARLOS, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Biomea or Biomea Fusion) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the presentation of preclinical data from its investigational menin inhibitor icovamenib in combination with semaglutide in a T2D animal model. The oral pres...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Hop Valley Brewing and Oregon Athletics Announce the Launch of Dang Green IPA, the First Official Craft Beer for the Oregon Ducks
News Preview
EUGENE, Ore., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hop Valley Brewing Co. (“Hop Valley Brewing” or “Hop Valley”), a trailblazer in the craft brewing industry and brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a leading global lifestyle and consumer packaged goods company, together with Oregon Athletics, are excited to announce the relea...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
WATERTOWN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outsi...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US88032L6056
Tenax Therapeutics, Inc.
TENX
LISTED
NASDAQ
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
News Preview
Provides Patent Protection in Europe Through at Least December 2040...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US9250501064
Verona Pharma plc
VRNA
LISTED
NASDAQ
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
News Preview
Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme
News Preview
Bagsværd, Denmark, 16 September 2025 – Novo Nordisk today presented data from a sub-analysis of the phase 3 REDEFINE 1 trial at the European Association for the Study of Diabetes (EASD) congress 2025 from 15–19 September in Vienna, Austria. This sub-analysis evaluated the efficacy and safety of once-weekly cagrilintide 2.4 mg monotherapy, plus life...
Themefolio
Profiler
Peergroup
© Newsfile
16.09.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence Therapeutics Appoints Dr. Amie Phinney as Director
News Preview
Montreal, Quebec--(Newsfile Corp. - September 16, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the appointment of Dr. Amie Phinney, PhD, MBA to its Board of Directors, effective immediately.D...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US03835L2079
Aptevo Therapeutics Inc.
APVO
LISTED
NASDAQ
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
News Preview
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing efficiently, Cohort 4 open for enrollment SEATTLE, WA / ACCESS Newswire / September 16, 2025 / Aptevo Therapeutics ("Aptevo" or "the Company") (NASDAQ:APVO), a cli...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US7389201077
Aspire Biopharma Holdings, Inc
ASBP
LISTED
NASDAQ
Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement
News Preview
Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ BOMB™ pre-workout:50mg caffeine for energy and focus.Boosts performance potential.Stick packs:Convenient, no water needed.Precise caffeine doseGlo...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US60458C1045
Mira Pharmaceuticals Inc
MIRA
LISTED
NASDAQ
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
News Preview
MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD MIAMI, FLORIDA / ACCESS Newswire / September 16, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutic...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company AnaCardio completes patient recruitment in phase 2a study of its drug candidate AC01
News Preview
STOCKHOLM, SWEDEN September 16, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has completed enrollment in the phase 2a part of its clinical study GOAL-HF1. The ongoing study evaluates AnaCardio’s drug candidate AC01 in patients with heart failure and reduced ejection fraction, with res...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron veröffentlicht die Ergebnisse des ersten Halbjahres 2025 und gibt ein Update zum Geschäftsverlauf
News Preview
Newron veröffentlicht die Ergebnisse des ersten Halbjahres 2025 und gibt ein Update zum Geschäftsverlauf
Mailand, Italien – 16. September 2025, 07:00 Uhr MESZ – Newron Pharmaceuticals S.p.A. („Newron”, ISIN: IT0004147952, SIX: NWRN, XETRA: NP5) gibt heute die finanziellen und operativen Höhepunkte des zum 30. Juni 2025 endenden Halbjahres bekannt......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron presents H1 2025 results and provides business update
News Preview
Newron presents H1 2025 results and provides business update
Milan, Italy, September 16, 2025, 07:00 am CEST – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its fina......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron veröffentlicht die Ergebnisse des ersten Halbjahres 2025 und gibt ein Update zum Geschäftsverlauf
News Preview
Newron veröffentlicht die Ergebnisse des ersten Halbjahres 2025 und gibt ein Update zum Geschäftsverlauf
Mailand, Italien – 16. September 2025, 07:00 Uhr MESZ – Newron Pharmaceuticals S.p.A. („Newron”, SIX: NWRN, XETRA: NP5), ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung neuartiger Therapien für Patienten mit Erkrankungen des ......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US12482V1035
CBD Life Sciences Inc.
CBDL
LISTED
OTC
CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025
News Preview
The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale beverage distribution in sports stadiums nationwide. SCOTTSDALE, ARIZONA / ACCESS Newswire / September 16, 2025 / CBD Life Sciences Inc. (OTC:CBDL), t...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: AU000000OCC6
Orthocell Limited
OCC
LISTED
ASX
Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
News Preview
Potential to reduce the risk of erectile dysfunction and urinary incontinence
PERTH, Australia, Sept. 16, 2025 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been introduced to Urologists in Australia for use in nerve-spa...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: AU000000OCC6
Orthocell Limited
OCC
LISTED
ASX
Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
News Preview
Potential to reduce the risk of erectile dysfunction and urinary incontinence
PERTH, Australia, Sept. 16, 2025 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been introduced to Urologists in Australia for use in nerve-spa...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
News Preview
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groupsClinical findings reinforce preclinical data supporting recent FDA approval of 2025-2026 formula of Spikevax CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) tod...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RXST Deadline: RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Did You Lose Money in LifeMD, Inc? If You Suffered Significant Financial Loss in LFMD Contact Robbins LLP for Information About Leading the LFMD Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired LifeMD, Inc. (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025. LifeMD is a leading provider of virtual primary care....
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Did You Lose Money in Semler Scientific, Inc.? If You Suffered Significant Financial Loss in SMLR Contact Robbins LLP for Information About Leading the SMLR Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025. Semler Scientific describes itself as a company that develops and markets techn...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: CH0011432447
Basilea Pharmaceutica AG Allschwil
BSLN
LISTED
SIX
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
Akeso's Ligufalimab (CD47 mAb) Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia (AML)
News Preview
HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that its proprietary next-generation humanized IgG4 monoclonal antibody targeting CD47, ligufalimab (AK117), has been granted Orphan Drug Designation (ODD) by the U.S. FDA for the treatment of acute myeloid leukemia (AML).
The Orphan Drug Designation is a program esta...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: KYG4818G1010
Innovent Biologics Inc
1801
LISTED
HKSE
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025
News Preview
SAN FRANCISCO and SUZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, ann...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference
News Preview
SECAUCUS, N.J., Sept. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during the Jefferies Healthcar...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting f...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ --
Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR).
If you c...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US10920G1004
Bright Green Corp
BGXX
LISTED
NASDAQ
Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman
News Preview
Tesla Robotics to Power Sovereign “Seed to Syringe” Pharmaceutical Infrastructure...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
News Preview
GALWAY, Ireland, Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045 (collective...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US71535D1063
Personalis, Inc.
PSNL
LISTED
NASDAQ
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on September 15, 2025, a non-qualified stock option to purchase an aggregate of 440,000 shares of its common stock to Personalis’ new Senior Vice President, Chief Information Offi...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US89157D1054
Tourmaline Bio Inc
TALS
LISTED
NASDAQ
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Tourmaline Bio, Inc. (NASDAQ: TRML)
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building ...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: CA0342231077
Andlauer Healthcare Group Inc
AND
LISTED
TSX
Andlauer Healthcare Announces Third Quarter Dividend
News Preview
TORONTO, Sept. 15, 2025 /CNW/ - Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced the Company's third quarter shareholder dividend (encompassing the period from July 1, 2025 to September 30, 2025) in the amount of $0.12 per subordinate voting share and multiple voting share. Payment will be made on October 15, 202...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US6907321029
Owens & Minor Inc
OMI
LISTED
NYSE
Apria and Byram Join New Optum Preferred DME Network
News Preview
Apria Healthcare, LLC and Byram Healthcare Centers, Inc., national leaders in home-based care and part of the Owens & Minor (NYSE: OMI) family, today announced a new national provider agreement with Optum Health – a patient-centered care organization that helps deliver better experiences for patients and providers, improve health outcomes and...
Themefolio
Profiler
Peergroup
© EQS Newswire
15.09.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah reicht Klage wegen Patentverletzung gegen Inspire Medical Systems, Inc. ein
News Preview
Nyxoah reicht Klage wegen Patentverletzung gegen Inspire Medical Systems, Inc. ein
Mont-Saint-Guibert, Belgien – 15. September 2025, 22:40 Uhr MESZ – Nyxoah SA (Euronext Brüssel/Nasdaq: NYXH) und Nyxoah, Inc. (zusammen „Nyxoah” oder das „Unternehmen”), ein Medizintechnikunternehmen, das innovative Technologien zur Behandlung der obstruktiven Schla......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.09.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
News Preview
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Mont-Saint-Guibert, Belgium – September 15, 2025, 10:40pm CET / 4:40pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah, Inc. (collectively, “Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstruc......
Themefolio
Profiler
Peergroup
© Newsfile
15.09.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000
News Preview
Montreal, Quebec--(Newsfile Corp. - September 15, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the closing of its previously announced non-brokered private placement of debenture units (...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
